[Effect of the modality of exposure on the action of S9788 on the modulation of multidrug resistance of human tumor cell lines].
Merlin
J L
JL
Laboratoire de recherche en oncologie, centre Alexis-Vautrin, Vandoeuvre-lès-Nancy, France.
Marchal
S
S
Ramacci
C
C
Lucas
C
C
Paraire
M
M
Poullain
M G
MG
D000230:Adenocarcinoma / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy; D016572:Cyclosporine / Q000494:pharmacology; D003630:Daunorubicin / Q000378:metabolism; D018432:Drug Resistance, Multiple; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D010880:Piperidines / Q000494:pharmacology*; D014227:Triazines / Q000494:pharmacology*; D014407:Tumor Cells, Cultured / Q000187:drug effects* / Q000378:metabolism; D014700:Verapamil / Q000494:pharmacology
D000970:Antineoplastic Agents; D010880:Piperidines; D014227:Triazines; C077022:S 9788; D016572:Cyclosporine; D014700:Verapamil; D003630:Daunorubicin
Influence des modalités d'exposition sur l'activité du S9788 dans la modulation de la multidrug resistance de lignées de cellules tumorales humaines.